Radiotherapy for the management of bone metastases in differentiated thyroid cancer
In this retrospective cohort study conducted at the Princess Margaret Cancer Center, a clear dose-response relationship was identified for patients with DTC bone metastases. When suitable, treatment of these patients should include a higher dose exceeding BED<sub>10</sub> = 40.
Authors
- Aruz Mesci (ORCID: https://orcid.org/0000-0002-8327-794X)
- Carly C. Barron (ORCID: https://orcid.org/0000-0002-9042-0150)
- Faisal Alfadli
- Ozgur Mete
- James R. Hurley
- Colin Faulkner
- Jelena Lukovic
- Lucy Ma
- Xiang Y. Ye
- Monika K. Krzyzanowska
Institutions
- University of Toronto (CA)
- Princess Margaret Cancer Centre (CA)
Publication Details
- Journal
- Clinical and Translational Radiation Oncology
- Published
- 2026-03-04
- DOI
- https://doi.org/10.1016/j.ctro.2026.101139
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00